Astria Therapeutics
VerifiedCatabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$219m (Public information from Jun 2024)
Share price
$9.1 ATXS
Cambridge Massachusetts (HQ)
Deals in current and previous year:
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | - | - | - | - | - | (11210 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | - | - | - | - | - | (11390 %) |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
* | $125m | Post IPO Equity | |
| Total Funding | 000k | ||
Related Content
Recent News about Astria Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Astria Therapeutics
Edit
ACQUISITION by Astria Therapeutics Feb 2021